Lavin; Thomas N
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lavin; Thomas N.The latest application filed is for "use of modafinil to treat restless leg syndrome".
- Lavin; Thomas N - Watchung NJ US
- Lavin; Thomas N. - Watchung NJ
- Lavin; Thomas N. - Sausalito CA
| Patent | Date |
|---|---|
| Strengthening wood frame construction against wind damage Grant 8,474,207 - Gilbert , et al. July 2, 2 | 2013-07-02 |
| Use Of Modafinil To Treat Restless Leg Syndrome App 20100010092 - Lavin; Thomas N. ; et al. | 2010-01-14 |
| Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds App 20020123521 - Lavin, Thomas N. | 2002-09-05 |
| Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds Grant 6,380,255 - Lavin April 30, 2 | 2002-04-30 |
| Selection method for pharmacologically active compounds Grant 5,500,807 - Lavin , et al. March 19, 1 | 1996-03-19 |
| Optical fluid detector Grant 4,816,695 - Lavin March 28, 1 | 1989-03-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 